Upcoming Live Programs

Upcoming
Rethinking wAMD: Is There a Consensus?
February 4, 2020
7:00 p.m. EST

On-Demand

Coming Soon
Optimizing Heart Failure Therapy - The Time is Now: Putting Evidence into Practice
December 5, 2019
Coming Soon
Deconstructing Cardiovascular Outcomes for Patients with Diabetes
December 5, 2019
Watch Now
Diabetes Mobile Apps: Benefits for Patients and Healthcare Professionals
November 13, 2019
Watch Now
The Evolving Landscape of Cutaneous Squamous Cell Carcinoma Treatment: Updates on Immunotherapy Treatment
October 30, 2019
Watch Now
15 min. Highlights from The Great Debate: Aspirin, DAPT or dual pathway inhibition for secondary prevention in stable ASCVD patients?
October 26, 2019
Watch Now
Staying Ahead of the Disease: The Impact of a Proactive Approach to wAMD Management
April 15, 2019
Watch Now
Highlights from the Latest ODYSSEY OUTCOMES Data: The Role of PCSK9 Inhibition Post-ACS
February 21, 2019
Watch Now
Highlights from the Latest ODYSSEY OUTCOMES Data: The Role of PCSK9 Inhibition Post-ACS
February 13, 2019
Watch Now
Faits saillants des toutes dernières données de l’étude ODYSSEY OUTCOMES : Rôle de l’inhibition de la PCSK9 après un SCA
February 13, 2019
Watch Now
Traitement anticoagulant chez les patients atteints d’insuffisance rénale
November 14, 2018
Watch Now
Anticoagulation in Patients with Renal Impairment
October 10, 2018
Watch Now
Breaking News from ATS.18
June 13, 2018
Watch Now
Prise en charge de l’anticoagulothérapie prolongée dans les cas de TEV
June 5, 2018
Watch Now
Managing Extended Anticoagulant Therapy in VTE
June 5, 2018
Watch Now
Ask the Experts: Hot Topics in Heart Failure Management
May 15, 2018
Watch Now
Translating the New Evidence in the Management of Type 2 Diabetes
January 23, 2018
Watch Now
Translating the New Evidence in the Management of Type 2 Diabetes
November 29, 2017
Watch Now
Translating the New Evidence in the Management of Type 2 Diabetes
November 21, 2017

Breaking News Series

Watch Now
Breaking News from ATS.18
June 13, 2018